69
Views
1
CrossRef citations to date
0
Altmetric
Review

The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm

, &
Pages 19-27 | Published online: 20 Jan 2012

Figures & data

Figure 1 Pathogenesis of the complex series of events in cystic fibrosis (CF) progressing to alveolar macrophage dysfunction via a TH2 dominated alveolar inflammation. (A) Denotes the interaction between the defective cystic fibrosis transmembrane conductance regulator (CFTR)−/− macrophages in respect to intracellular acidification and Gram-negative infection, an interaction involving a T-cell switch (B) to an alveolar T-helper 2 response with induction of B-cell activation with antibody formation, transforming CF into an immunological allergic disease characterized by increased systemic immunoglobulin formation (IgG and IgE). The TH2 response has been connected with an unfavorable accelerated declined spirometry. The end stage of the altered alveolar environment (C) with alveolar macrophage dysfunction, reflected by (i) reduced antigen (Ag) presentation, (ii) enhanced tolerance toward lipopolysaccharide (LPS) and finally (iii) reduced expression of recognition receptors, the so-called toll-like receptors (TLR) where TLR-4, which recognizes Gram-negatives, is decreased. In the end, remodeling of peripheral airways will take place producing a reduced alveolar host defense.

Figure 1 Pathogenesis of the complex series of events in cystic fibrosis (CF) progressing to alveolar macrophage dysfunction via a TH2 dominated alveolar inflammation. (A) Denotes the interaction between the defective cystic fibrosis transmembrane conductance regulator (CFTR)−/− macrophages in respect to intracellular acidification and Gram-negative infection, an interaction involving a T-cell switch (B) to an alveolar T-helper 2 response with induction of B-cell activation with antibody formation, transforming CF into an immunological allergic disease characterized by increased systemic immunoglobulin formation (IgG and IgE). The TH2 response has been connected with an unfavorable accelerated declined spirometry. The end stage of the altered alveolar environment (C) with alveolar macrophage dysfunction, reflected by (i) reduced antigen (Ag) presentation, (ii) enhanced tolerance toward lipopolysaccharide (LPS) and finally (iii) reduced expression of recognition receptors, the so-called toll-like receptors (TLR) where TLR-4, which recognizes Gram-negatives, is decreased. In the end, remodeling of peripheral airways will take place producing a reduced alveolar host defense.

Table 1 Comparison of two subsets TH1 and TH2 each consisting of T-cells and a corresponding cytokine pattern

Table 2 Overview of potential surrogate markers in relation to monitoring the efficacy of inhaled GM-CSF